FathomX is a Medical Imaging AI Spin-Off for breast cancer analysis from the National University of Singapore
FathomX's investors include TMU BioMed Accelerator.
FathomX is headquartered in Singapore, Singapore.
FathomX is a Medical Imaging AI Spin-Off for breast cancer analysis from the National University of Singapore
FathomX is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FathomX — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/fathomx. Accessed August 13, 2026.
VCBacked. (2023). FathomX — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/fathomx
{{cite web |title=FathomX — Funding & Investors |url=https://www.vcbacked.co/company/fathomx |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated